22nd Century Announces 1-for-135 Reverse Stock Split
22nd Century Announces 1-for-135 Reverse Stock Split
Mocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of 1-for-135, to be effective as of December 17, 2024. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
北卡羅來納州莫克斯維爾--(Newsfile Corp. - 2024年12月13日)- 22nd Century Group, Inc.(納斯達克:XXII),一家在菸草製品行業中領先抵制尼古丁的公司,認爲吸菸者應該有權選擇其尼古丁消費,今天宣佈將以1比135的比例實施反向股票分割,生效日期爲2024年12月17日。反向股票分割的目的是使公司重新符合納斯達克對普通股最低買盤價格1.00美元的要求,以繼續上市。
Lawrence Firestone, Chief Executive Officer said, "Over the past year since joining the Company, we have made significant changes which have improved our operating model and balance sheet. We are moving quickly to activate our new VLN strategy which includes deploying private label VLN brands. We are on track to become EBITDA profitable as early as the first quarter of 2025. With our operating improvements and recent actions, we recently regained compliance with the shareholder's equity requirement, and this last step will enable us to regain compliance with the Nasdaq minimum bid price requirement as we continue to work toward creating long-term shareholder value."
首席執行官勞倫斯·法爾斯通表示:「自加入公司以來的過去一年裏,我們進行了重大變革,改善了我們的運營模式和資產負債表。我們正在迅速啓動我們的新VLN策略,包括推出私人標籤的VLN品牌。我們有望在2025年第一季度早期實現EBITDA盈利。通過我們的運營改進和近期行動,我們最近重新符合股東權益要求,這最後一步將使我們能夠重新符合納斯達克最低買盤價格的要求,同時我們將繼續努力創造長期股東價值。」
22nd Century Common Stock will begin trading on a reverse stock split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on Tuesday, December 17, 2024. Following the reverse stock split, the Common Stock will continue to trade on Nasdaq under the symbol "XXII" with the new CUSIP number, 90137F400.
22nd Century普通股將於2024年12月17日星期二在納斯達克資本市場(「納斯達克」)以反向股票分割調整後的方式開始交易。在反向股票分割後,普通股將繼續在納斯達克以標的「XXII」交易,並擁有新的CUSIP編號90137F400。
The reverse stock split will consolidate the number of issued and outstanding shares of the Company's common stock to approximately 504,000.
反向股票分割將把公司發行和流通的普通股數量合併至大約504,000股。
About 22nd Century Group, Inc.
關於22nd Century Group, Inc.
22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption.
22nd Century Group是菸草行業中開創性的尼古丁危害減少公司,使吸菸者能夠掌控他們的尼古丁消費。
We created our flagship product, the VLN cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them take control of their nicotine consumption. VLN cigarettes have 95% less nicotine than the traditional cigarette and have been proven to greatly reduce nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether.
我們創造了旗艦產品VLN香菸,以便爲傳統香菸吸菸者提供一種真實且熟悉的替代品,幫助他們掌控尼古丁消費。VLN香菸的尼古丁含量比傳統香菸減少95%,已被證明能大幅降低尼古丁消費。我們不是爲上癮的吸菸者提供新的尼古丁輸送方式,而是爲吸菸者提供掌控尼古丁消費並作出可知情的更有效選擇的機會,包括選擇完全避免成癮水平的尼古丁。
Our wholly owned subsidiaries include a leading cigarette manufacturer that produces all VLN products and provides turnkey contract manufacturing for other tobacco brands both domestically and internationally. The 60,000 square foot facility in Mocksville, North Carolina has the capacity to produce more than 45 million cartons of combusted tobacco products annually with additional space for expansion.
我們的全資子公司包括一家領先的香菸製造商,該公司生產所有VLN產品,併爲其他菸草品牌提供全面的合同製造服務,涵蓋國內和國際市場。位於北卡羅來納州莫克斯維爾的60,000平方英尺的設施每年能夠生產超過4500萬箱燃燒的菸草製品,並且還有擴展空間。
Our proprietary reduced nicotine tobacco blends are made possible by comprehensive and patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets. Our mission is to sell the last cigarette before the 22nd Century.
我們的專有低尼古丁菸草混合物得益於綜合且獲得專利的技術,這些技術調節菸草植物中的尼古丁生物合成活動,從而實現 plenamente 的風味和高產量,同時降低95%的尼古丁含量。我們廣泛的專利組合已得以發展,以確保我們在美國及關鍵國際市場上擁有唯一的低尼古丁可燃香菸。我們的使命是在22世紀之前銷售最後一支香菸。
VLN and Helps You Smoke Less are registered trademarks of 22nd Century Limited LLC.
VLN和降低吸菸量的Helps You Smoke Less是22nd century Limited LLC的註冊商標。
Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.
了解更多請訪問 xxiicentury.com,在 X(前身爲Twitter),在 LinkedIn,並且在 YouTube.
Learn more about VLN at tryvln.com.
了解更多關於VLN的信息。 tryvln.com.
Cautionary Note Regarding Forward-Looking Statements
關於前瞻性聲明的警示說明
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024, and in the Company's Quarterly Reports filed on May 15, 2024, August 13, 2024 and November 11, 2024. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.
除歷史信息外,本新聞稿中包含的所有聲明、預期和假設均爲前瞻性聲明,包括但不限於我們全年的業務展望。前瞻性聲明通常包含諸如「預期」、「相信」、「考慮」、「繼續」、「可能」、「估計」、「期望」、「探索」、「預見」、「目標」、「指導」、「打算」、「可能」、「也許」、「計劃」、「潛在」、「預測」、「初步」、「可能」、「項目」、「有希望」、「尋求」、「應該」、「將」、「會」等類似表達。前瞻性聲明包括但不限於以下方面的聲明:(i)我們的成本削減計劃,(ii)我們對監管執行的預期,包括我們獲得新法規豁免的能力,(iii)我們的財務和運營表現以及(iv)我們對業務中斷保險索賠的預期。實際結果可能與前瞻性聲明中明確或隱含的結果有重大不同。可能導致實際結果與預期顯著不同的重要因素列在2024年3月28日提交的公司10-K年報的「風險因素」中,以及在2024年5月15日、2024年8月13日和2024年11月11日提交的公司季度報告中。本聲明中提供的所有信息均截至本日期,公司沒有義務也不打算更新這些前瞻性聲明,除非法律要求。
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200
投資者關係與媒體聯繫方式
馬特·克雷普斯
投資者關係
22世紀集團
mkreps@xxiicentury.com
214-597-8200
譯文內容由第三人軟體翻譯。